Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3
for Juvenile Neuronal Ceroid Lipofuscinosis
Sponsor: Polaryx Therapeutics, Inc.
Sex: All·Age: 6 - 18
Code: NCT04637282·Phase 3·Not Yet Recruiting
11 active Batten Disease trials currently recruiting in the US, sourced from ClinicalTrials.gov.
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
Cities where Batten Disease trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.
Currently recruiting US trials matching Batten Disease, sourced live from ClinicalTrials.gov. We’ll add per-event articles here as those trials post results or hit primary completion.